Phagos
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A phage therapy company developing targeted antibacterial cocktails to fight antibiotic-resistant infections.
Infectious Disease
Technology Platform
A platform for discovering, optimizing, and formulating natural and engineered bacteriophage cocktails to treat multidrug-resistant bacterial infections.
Opportunities
Addressing the critical and growing unmet need for treatments against multidrug-resistant bacterial infections.
Risk Factors
Regulatory uncertainty and the challenge of developing standardized, scalable manufacturing for complex biological cocktails.
Competitive Landscape
Part of a emerging but fragmented global phage therapy sector, competing with companies like Adaptive Phage Therapeutics and Locus Biosciences.